sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

North America Cancer Vaccines Market Size & Forecast

Download Free Sample View Report Summary
Historic: 2017-2018 Base Year: 2019 Forecast: 2020–2027
US$ 1,875.7 Million
Market Size 2019 · Base Year
US$ 6,623.6 Million
Projected Market Size by 2027
17.5%
CAGR · 2020–2027
Download Free Sample View Report Summary
sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608
SHARE
TIPRE00015129 3+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
3+ countries across North America
11
Year Assessment
Comprehensive Market Analysis Covering 2 Years of Historical Data (2017–2018), Base Year (2019), and 8-Year Forecast (2020–2027)
10 +
Major Players
Major companies profiled including AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi
164
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Increase in Prevalence of Cancer Worldwide

Where Growth Opportunities Exist

Key Opportunities

  • Growing Research and Development Activities

What Could Slow It Down

Market Restraints

Market Segmentation

Coverage by Segment

Technology

Dendritic Cells Cancer Vaccines
Recombinant Cancer Vaccines
Antigen Cancer Vaccines

Type

Preventive Cancer Vaccines
Therapeutic Cancer Vaccines

Indication

Cervical Cancer
Prostate Cancer
Other Indications

End User

Pediatrics
Adults
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

AstraZeneca
GlaxoSmithKline plc.
Aduro Biotech Inc
Pfizer Inc.
Sanofi
Bristol-Myers Squibb
Moderna, Inc.
OncBioMune Pharmaceuticals Inc.
MaxiVAX
Nouscom
What's Inside

Report Scope & Deliverables

Market Size 2019 US$ 1,875.7 Million
Market Size 2027 US$ 6,623.6 Million
CAGR 2020–2027 17.5%
Segments By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines)  |  By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines)  |  By Indication (Cervical Cancer, Prostate Cancer, Other Indications)
Geographies North America (US, Canada, Mexico)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code TIPRE00015129
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 164 pages of in-depth North America Cancer Vaccines Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

View Report Summary Download Free Sample